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Glucose-rich diets shorten the life spans of various organisms. However, the metabolic processes involved in this
phenomenon remain unknown. Here, we show that sterol regulatory element-binding protein (SREBP) and media-
tor-15 (MDT-15) prevent the life-shortening effects of a glucose-rich diet by regulating fat-converting processes in
Caenorhabditis elegans. Up-regulation of the SREBP/MDT-15 transcription factor complex was necessary and
sufficient for alleviating the life-shortening effect of a glucose-rich diet. Glucose feeding induced key enzymes that
convert saturated fatty acids (SFAs) to unsaturated fatty acids (UFAs), which are regulated by SREBP and MDT-15.
Furthermore, SREBP/MDT-15 reduced the levels of SFAs and moderated glucose toxicity on life span. Our study
may help to develop strategies against elevated blood glucose and free fatty acids, which cause glucolipotoxicity in
diabetic patients.
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Glucose is an essential energy source for many cellular
processes and should be tightly regulated to maintain or-
ganismal health. Abnormal glucose metabolism is linked
to obesity and pathological conditions, such as diabetes
mellitus and cardiovascular diseases. Glucose reduces
the life spans of model organisms, including Caenorhab-
ditis elegans, by influencing various factors that regulate
aging (Schulz et al. 2007; Lee et al. 2009; Schlotterer et
al. 2009).
Glucose and fat metabolisms are tightly linked. Exces-
sive amounts of dietary carbohydrates, including glucose,
are stored as lipids. Elevated levels of blood glucose and
fats correlate with increased risks of cardiovascular dis-
eases, diabetes, and specific types of cancers. Fatty acid
(FA) deficiency is also linked to many disorders, including
growth disturbance, infertility, and kidney failure (for re-
view, see Kremmyda et al. 2011). Emerging evidence indi-
cates that fat metabolism affects life span. Several C.
elegans mutants with impaired fat metabolism have re-
duced life spans (Van Gilst et al. 2005; Taubert et al.
2006). Interestingly, some mutant worms with long life
span display increased fat (Kimura et al. 1997; O’Rourke
et al. 2009; Shi et al. 2013), whereas others are low in fat
(Heestand et al. 2013). Thus, it remains unclear whether
fat metabolism plays a causal role in the regulation of C.
elegans life span.
Sterol regulatory element-binding proteins (SREBPs)
are key transcription factors that govern fat metabolism.
A high carbohydrate diet activates mammalian SREBPs
and induces expression of lipogenic genes, including ace-
tyl-CoA carboxylase (ACC), FA synthase (FAS), and
stearoyl-CoA desaturase 1 (SCD1) (Horton et al. 1998;
Hasty et al. 2000). These lipogenic genes are crucial for
normal fatmetabolism and organismal viability, as shown
by mouse knockout studies (Abu-Elheiga et al. 2001; Mi-
yazaki et al. 2001; Chirala et al. 2003). The mechanisms
through which SREBPs regulate lipid metabolism appear
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to be conserved in C. elegans (McKay et al. 2003; Walker
et al. 2010, 2011). The C. elegans SREBP homolog SBP-1
and the transcriptional coregulator mediator-15 (MDT-
15) cooperatively control the expression of lipogenic
genes, including those that encode SCDs (Taubert et al.
2006; Yang et al. 2006; Nomura et al. 2010; Walker et al.
2010). The SCDs catalyze the generation of unsaturated
FAs (UFAs) by adding double bonds to the carbon chain
in saturated FAs (SFAs). SREBP and its downstream
enzymes appear to play key roles in various aspects of an-
imal physiology, including reproduction and development
(Yang et al. 2006; Brock et al. 2007).
The goal of this study was to identify genes that affect
the ability of a glucose-rich diet to reduce life span. We
performed a genome-wide RNAi screen on C. elegans
that expressed a novel glucose reporter GFP.We identified
>200 genes that potentially modulated the effects of die-
tary glucose on life span.We found that genetic inhibition
of MDT-15 or SREBP further decreased the short life span
of glucose-fed worms. Conversely, up-regulation of MDT-
15 or SREBP restored normal life span in glucose-fed con-
ditions. Dietary glucose increased the level of SREBP,
which induced several key enzymes that convert SFAs
to UFAs. In addition, SREBP/MDT-15 was necessary and
sufficient for ameliorating the accumulation of SFAs dur-
ing glucose feeding. Furthermore, the increasedmetabolic
flow from glucose via SFA-to-UFA synthesis moderated
the toxic effects of glucose on life span. These data indi-
cate that reduction of SFAs by SREBP/MDT-15 prevents
the accelerated aging caused by a high glucose diet.
Results
far-3p::GFP is a glucose-responsive, fluorescentC. elegans
Wesought toestablishaglucose reporter thatcouldbeused
in a genetic screen.We examined four available transgenic
animals that expressed GFP under the control of glucose-
responsive gene promoters (Supplemental Fig. S1A; Lee
et al. 2009). Transgenic worms that expressed GFP under
the control of the FA/retinol-binding protein 3 ( far-3) pro-
moter ( far-3p::GFP) displayed prominent and consistent
induction of fluorescence upon glucose feeding (Fig. 1A,
B; Supplemental Fig. S1A). Expression of far-3p::GFP was
also moderately induced in response to various sugars
and sugar metabolites, including fructose, trehalose, and
glycerol, which can be converted from and to glucose in
vivo (Supplemental Fig. S1B,C). In contrast, far-3p::GFP
was hardly induced by the following potential glucose-
related stressors: elevated osmolarity by NaCl treatment,
oxidative stress by paraquat treatment, endoplasmic retic-
ulum (ER) stress by tunicamycin treatment, and increased
temperature (Supplemental Fig. S1D–K). These results
established far-3p::GFP as an in vivo glucose reporter.
A genome-wide RNAi screen identifies genes that
modulate the life-reducing effect of glucose
We performed a genome-wide screen to identify RNAi
clones that influenced far-3p::GFP expression in response
to glucose feeding (Fig. 1C). We found that 170 enhancer
and 44 suppressor RNAi clones reproducibly increased
and decreased, respectively, the expression of far-3p::
GFP on a glucose-rich diet (Supplemental Tables S1, S2).
Gene ontology (GO) analysis indicated that genes in-
volved in endocytosis, RNA splicing, cell division, and
protein catabolism were enriched in the enhancer RNAi
clones (Fig. 1D,E). Genes involved in FA metabolism,
apoptosis, lipid storage, mRNA metabolism, and aging
were overrepresented in the suppressor RNAi clones
(Fig. 1D,F). Next, we examined the effects of the sup-
pressor RNAi clones on the life-shortening effects of glu-
cose (Supplemental Table S1). RNAi targeting mdt-15,
C35A5.8, let-526, hpo-34, tag-260, or F35F11.3 differen-
tially affected life span in glucose-fed versus control con-
ditions (Fig. 1G; Supplemental Fig. S2A–E and see the
legend for details; Supplemental Table S1.). Thus, our ge-
nome-wide RNAi screen and life span assays identified
genes that modulated the life-reducing effect of glucose.
MDT-15 and SBP-1 protect against life-reducing
glucose toxicity
mdt-15 RNAi or mutation suppressed the induction of
far-3 by glucose (Supplemental Fig. S3A–C) and further
shortened the life span of animals in glucose-fed con-
ditions (Figs. 1G, 2A; Supplemental Fig. S3D–F; Supple-
mental Table S1). MDT-15 functions as a transcriptional
coregulator of fat metabolism and stress responses
through interacting with transcription factors, including
SREBP/SBP-1, nuclear hormone receptor-49 (NHR-49),
and nuclear factor–erythroid-related factor 2 (Nrf2 [SKN-
1]) (Taubert et al. 2006; Yang et al. 2006; Goh et al.
2014; Pang et al. 2014). sbp-1 RNAi or mutation substan-
tially reduced life span in glucose-fed conditions, similar
to that observed withmdt-15 RNAi (Fig. 2B; Supplemen-
tal Fig. S3G–I). In contrast, inhibition ofNHR-49 or SKN-1
decreased life span independently of glucose feeding
(Supplemental Fig. S3J,K). Consistent with the idea that
SBP-1 and MDT-15 act together as a complex, genetic in-
hibition of sbp-1 did not further decrease the short life
span of mdt-15(RNAi) worms on a glucose-rich diet (Fig.
2C,D). Knockdown of mdt-15 or sbp-1 also dramatically
accelerated age-dependent declines in movement and
feeding capacities upon glucose feeding (Fig. 2E,F; Supple-
mental Fig. S4A–J). These results suggest that MDT-15
and SBP-1 function together to protect worms from proge-
ria in glucose-rich conditions.
We examined tissue-specific effects of MDT-15 and
SBP-1 on life span in response to a glucose-rich diet. As re-
ported previously (McKay et al. 2003; Taubert et al. 2006;
Walker et al. 2010), GFP expression driven by an mdt-15
promoter (mdt-15p::GFP) or an sbp-1 promoter (sbp-1p::
GFP) was detected in multiple tissues (Supplemental
Fig. S5A,B). RNAi against mdt-15 in the intestine, hypo-
dermis, or neurons significantly shortened the life span
of glucose-treated animals; mdt-15 RNAi in body wall
muscle did not (Fig. 2G; Supplemental Fig. S5C–G; see
the legends for the Supplemental Figures for further dis-
cussion). Intestine-specific sbp-1 RNAi further decreased
SREBP/MDT-15 prevents glucose-induced short life
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Figure 1. A genome-wide RNAi screen using a glucose-responsiveGFP reporterC. elegans. (A) Addition of various concentrations of glu-
cose significantly induced far-3p::GFP. Bar, 200 μm. (B) Quantification of the GFP intensity inA. Error bars represent standard error of the
mean (SEM). (∗∗∗) P < 0.001, two-tailed Student’s t-tests. n≥ 40 from two independent experiments. (C ) Experimental design of the ge-
nome-wide RNAi screen. far-3p::GFP transgenic animals were cultured on dsRNA-expressing bacteria on 24-well solid NGM plates con-
taining 2% glucose. Changes in fluorescence intensity for enhancer and suppressor RNAi clones were blindly and independently screened
by three researchers. (D) A gene interaction network and gene ontology (GO) terms among enhancer and suppressor hits from our RNAi
screen were analyzed by STRING (Search Tool for the Retrieval of Interacting Genes/Proteins) (Szklarczyk et al. 2015) and DAVID (Da-
tabase for Annotation, Visualization, and Integrated Discovery) (Huang et al. 2009). (E,F ) GO terms annotated in the enhancer (E) and sup-
pressor (F ) RNAi clones, which increased and decreased the level of far-3p::GFP, respectively. (∗) P < 0.05; (∗∗) P < 0.01; (∗∗∗) P < 0.001,
modified Fisher’s exact tests (Huang et al. 2009). Because glucose and fat metabolism are closely related to each other, genes involved
in FA metabolism may have been enriched in the suppressor RNAi clones. One noticeable caveat for this explanation is that far-3 is a
FAmetabolism-related gene, and thismay have skewed our screen data for fatmetabolism-related genes. (G) Percentmean life span chang-
es by the suppressor RNAi clones from our screen with (Y-axis) or without (X-axis) additional glucose treatment compared with control
RNAi. The life-shortening effect ofmdt-15 RNAi (red) was much higher in glucose-enriched conditions than in control conditions. We
also found that far-3 RNAi did not affect life span with or without additional glucose feeding (Supplemental Fig. S1L). See Supplemental
Table S3 for statistical analysis of the life span data.
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the short life span of glucose-fedworms,whereas hypoder-
mis-specific or body wall muscle-specific sbp-1 RNAi did
not (Fig. 2H; Supplemental Fig. S5H–L). Thus, the intes-
tine is a common tissue in which inhibition of mdt-15
or sbp-1 exacerbated the life span-shortening effects of
glucose feeding.
Up-regulation of SBP-1/MDT-15 during glucose feeding
protects animals from glucose toxicity
Next, we examined whether a glucose-rich diet influ-
enced the activity of SBP-1 or MDT-15. Glucose-rich
diet feeding increased overall levels of GFP-fused SBP-1
in intestinal cells (Fig. 3A,B; Supplemental Fig. S6A,B)
while not increasing the mRNA levels of sbp-1 (Supple-
mental Fig. S6C). We also found that glucose treatment
did not affect the level or expression pattern of MDT-15-
GFP or mdt-15 mRNA (Fig. 3C; Supplemental Fig. S6D).
Thus, dietary glucose appears to increase SBP-1 protein
levels post-transcriptionally.
We next asked whether up-regulation of SBP-1 orMDT-
15 moderates the toxic effects of glucose on life span. An
mdt-15 gain-of-function (gf) mutation, et14 (Svensk et al.
2013), restored normal life span in glucose-fed worms (Fig.
3D; Supplemental Fig. S7A). Similarly, the life span-reduc-
ing effect of glucose was significantly suppressed by sbp-1
overexpression (Fig. 3E; Supplemental Fig. S7B). Muta-
tions in the S-adenosyl methionine synthetase gene
(sams-1), which increase the activity of SBP-1 (Walker
et al. 2011), conferred resistance to the life-shortening ef-
fects of glucose (Fig. 3F; Supplemental Fig. S7C). The
life span-restoring effects of sams-1mutations in high glu-
cose conditions were largely dependent on mdt-15 and
sbp-1 (Fig. 3G,H; Supplemental Fig. S7D,E). Thus, up-reg-
ulation of the SBP-1/MDT-15 complex appears to protect
animals from the life-reducing effect of excessive dietary
glucose.
Glucose feeding induces FA desaturases, transcriptional
targets of SBP-1/MDT-15
We performed RNA sequencing to measure the mRNA
levels of genes that were differentially expressed by a glu-
cose-rich diet and SBP-1/MDT-15 (P < 0.05, fold change
>1.2) (Fig. 4A–D; Supplemental Fig. S8A–E). SBP-1 and
MDT-15 shared a large number of common targets (Fig.
4C,D; Supplemental Fig. S8F–I), consistent with their
roles as components of a transcription factor complex.
Expression of a large subset of glucose-responsive genes
was dependent on SBP-1 andMDT-15 (Fig. 4A–D). Various
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Figure 2. MDT-15 and SBP-1 are required
for protecting worms from living too short
upon glucose treatment. (A,B) Genetic inhi-
bition of mdt-15 (A) or sbp-1 (B) by RNAi
further shortened life span upon glucose
treatment. (C,D) Shown are life span curves
of worms treated withmdt-15/sbp-1 double
RNAi on a glucose-rich diet (C ) and a control
diet (D). sbp-1 RNAi treatment did not fur-
ther shorten the life span of mdt-15 RNAi-
treated worms. Note that mdt-15(RNAi)
worms may have lived too short upon glu-
cose feeding to display further decreases in
life span. (E,F ) Knockdown of mdt-15 (E) or
sbp-1 (F ) enhanced age-dependent declines
in motility (body bends in liquid) on a glu-
cose-rich diet. (∗∗∗) P < 0.001; P-values were
calculated by using two-way ANOVA test.
Error bars represent SEM. n = 15. Other mo-
tility assays—including measurements of
body bends in solid medium and feeding
rate—and additional repeats are shown in
Supplemental Figure S4. See Supplemental
Table S5 for statistical analysis of all of the
measurements in E and F and Supplemental
Figure S4. (G,H) mdt-15 RNAi (G) or sbp-1
RNAi (H) specifically in the intestine by us-
ing an nhx-2 promoter-driven rde-1 in an
RNAi-defective rde-1(ne219) mutant back-
ground further decreased the short life span
of glucose-fed worms. For the life span and
motility assays, worms were treated with
mdt-15 RNAi only during adulthood and
were treated with sbp-1 RNAi for their
whole lives. See the Supplemental Material for details. See Supplemental Tables S4 and S6 for additional repeats and statistical analysis
of the life span data shown in this figure.
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GO terms, including lipid metabolism and carbohydrate
metabolism, were significantly enriched among the glu-
cose-responsive genes whose expression was dependent
on SBP-1 and MDT-15 (Fig. 4E,F). Overall, these data sug-
gest that SBP-1 and MDT-15 regulate the expression of
many common metabolic genes upon glucose-rich diet
feeding.
FA biosynthesis was significantly enriched among SBP-
1/MDT-15-dependent glucose-induced GO terms (Fig.
4E). In particular, expression of the SCD1 homolog FAT-
7 was substantially reduced in both sbp-1(RNAi) and
mdt-15(RNAi) worms (Supplemental Table S8; Taubert
et al. 2006; Yang et al. 2006; Nomura et al. 2010). FAT-7
is a key enzyme for FA biosynthesis and conversion of
SFAs to monounsaturated FAs (MUFAs) and polyunsatu-
rated FAs (PUFAs) (Fig. 5A). We confirmed the mRNA se-
quencing results of fat-7 by using GFP transgenic animals
(Fig. 5B,C). We then expanded our expression analysis to
include all seven C. elegans FA desaturases ( fat-1 to fat-
7). A glucose-rich diet induced fat-1, fat-2, fat-5, fat-6,
and fat-7 (Fig. 5D–G; Supplemental Fig. S9A–G), although
the expression of fat-2 and fat-6was variable depending on
the types of bacterial foods (Supplemental Fig. S9H–K; see
the legends for the Supplemental Figures for discussion).
RNAi targeting mdt-15 or sbp-1 reduced the expression
of fat-2, fat-5, fat-6, and fat-7 (Fig. 5D–G; Supplemental
Fig. S9D–G). Moreover, sbp-1 overexpression, the mdt-
15 gain-of-function mutation, or the sams-1mutation in-
duced these FA desaturases (Fig. 5H–L; Supplemental Fig.
S9H–K; Walker et al. 2011). Thus, glucose feeding appears
to increase the expression of multiple FA desaturases,
which are targets of the SBP-1/MDT-15 complex.
We next determined the role of these multiple fat genes
in the life-reducing effects of dietary glucose. We found
that intestinal overexpression of FA desaturases ( fat-2,
fat-5, fat-6, and fat-7) significantly suppressed the short
life span of sbp-1(RNAi) worms on a glucose-rich diet
(Fig. 5M); the results with RNAi knockdown of these fat
genes were inconclusive (Supplemental Fig. S10C,D and
see the legend for details). These data suggest that FA
desaturases can reduce the toxic effects of dietary glucose
on life span.
Figure 3. SBP-1 andMDT-15 are sufficient
for detoxifying the effects of glucose on life
span. (A) Glucose-rich diet feeding increased
the fluorescence intensity of GFP-SBP-1
proteins in the intestinal cells of IJ1208
sbp-1p::GFP::sbp-1 animals (L4 larvae). Ar-
rowheads indicate the intestinal nuclei.
Bar, 100 μm. Yellow boxes indicate the
enlarged regions in A and C. We confirmed
this result by using another GFP-SBP-1
transgenic strain, epEx141[sbp-1p::GFP::
sbp-1; rol-6(su1006)] (Supplemental Fig.
S6A,B; Walker et al. 2011). Fructose, anoth-
er sugar, also increased GFP-SBP-1 levels
and decreased life span (Supplemental Fig.
S6E–G). (B) Quantification of GFP-SBP-1
levels in A. n≥ 21 from three independent
experiments. (C ) Glucose feeding did not af-
fect the expression pattern of MDT-15-GFP
proteins in mdt-15p::mdt-15::GFP animals
(L2 larvae). Bar, 50 μm. (D) The mdt-15
(et14) gain-of-function (gf) mutation sup-
pressed the shortened life span of worms
fed with a glucose-rich diet. Please note
that all animals that were used for the life
span assay in D contained paqr-2(tm3410)
mutations because the mdt-15(et14) muta-
tion is very closely linked (0.33 cM) to
paqr-2(tm3410) mutations (Svensk et al.
2013). (E) sbp-1 overexpression (sbp-1 OE;
sbp-1p::GFP::sbp-1) largely restored nor-
mal life span in glucose-rich conditions. In-
jection marker (roller) transgenic worms
(CF1290) were used as a control. (F ) sams-1
(ok3033) [sams-1(−)] mutation suppressed short life span caused by glucose-rich diet feeding. mdt-15(gf), sbp-1 overexpression, and
sams-1(−) also suppressed the life span-shortening effect of 0.2% dietary glucose (Supplemental Fig. S7A–C). (G,H) Knockdown of
mdt-15 (G) or sbp-1 (H) suppressed the restored life span by sams-1 mutation upon glucose-rich diet feeding. Note that inhibition of
sams-1 increases life span (Hansen et al. 2005; Cabreiro et al. 2013; Ding et al. 2015), but we found that the sams-1(ok3033) mutation
had little or no life span-extending effect in our experimental conditions. We speculate that different experimental conditions (e.g., bac-
terial food source) may have caused the different results. See Supplemental Table S7 for additional repeats and statistical analysis for
the life span data shown in this figure.
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SBP-1/MDT-15 converts SFAs to UFAs during
glucose-rich diet feeding
We examined whether MDT-15 and SBP-1 affected life
span bymodulating fatmetabolism in response to glucose
feeding. We used various methods, including Oil-Red-O
and Nile Red staining and coherent anti-Stokes Raman
scattering (CARS) imaging, to measure internal fat levels.
Consistent with previous reports (Schulz et al. 2007;
Nomura et al. 2010; Pang et al. 2014), glucose treatment in-
creased the overall fat levels (Fig. 6A,B; Supplemental Fig.
S11A–D).The sbp-1(RNAi) animals displayed reduced lev-
els of fat (Fig. 6A,B; Supplemental Fig. S11A–D), as previ-
ously shown (Ashrafi et al. 2003; McKay et al. 2003;
Yang et al. 2006; Nomura et al. 2010). The effects of
mdt-15 RNAi varied among the different assays (Fig 6A,
B; Supplemental Fig. S11A–D), consistent with previous
reports (Taubert et al. 2006; Arda et al. 2010). We found
that a glucose-rich diet increased overall fat levels in sbp-
1(RNAi) and mdt-15(RNAi) animals (Fig. 6A,B; Supple-
mental Fig. S11A–D), although the data showa substantial
variability (Fig. 6B; Supplemental Fig. S11E). This result
suggests that other factors that act in parallel to SBP-1/
MDT-15 contribute to the accumulation of overall fat
upon glucose feeding in addition to SBP-1 and MDT-15.
We next performed gas chromatography/mass spec-
trometry (GC/MS) analysis to measure the composition
of FAs in glucose-fed animals treated with sbp-1 RNAi
ormdt-15RNAi. The overall triacylglyceride (TAG) levels
measured by GC/MS (Fig. 6C) were consistent with re-
sults obtained through other assays (Fig. 6A,B; Supple-
mental Fig. S11A–D). Glucose feeding increased the
levels of SFAs (C14:0 and C16:0) and several types of
MUFAs (C16:1n-7, C18:1n-9, and C18:1n-7) but did not
increase the levels of PUFAs (Fig. 6D). Knockdown of
sbp-1 or mdt-15 resulted in the accumulation of SFAs
(C14:0, C16:0, and C18:0) (Fig. 6E; Supplemental Fig.
S11F) but decreased the levels of MUFAs and PUFAs (in
particular, C18:1n-9 andC18:2n-6) (Fig. 6F,G; Supplemen-
tal Fig. S11F; Taubert et al. 2006; Yang et al. 2006). Impor-
tantly, glucose feeding further increased the levels of SFAs
(C14:0 and C16:0) inmdt-15(RNAi) and sbp-1(RNAi) ani-
mals (Supplemental Fig. S11F) while having a small effect
on the levels of UFAs, particularly PUFAs (Fig. 6F,G;
Supplemental Fig. S11F). Conversely, sbp-1 overexpres-
sion, the mdt-15(gf) mutation, or the sams-1 mutation
consistently decreased overall SFA levels while having
variable effects on UFA levels (Fig. 6H–J; Supplemental
Fig. S12A–I). These results suggest that SBP-1 and MDT-
15 counteract the accumulation of SFA-containing fat
upon high glucose diet feeding.
The accumulation of SFAs and intermediate
metabolites in glycolysis appears to reduce
life span on a glucose-rich diet
Are the changes in fat composition responsible for the
shortened life span of glucose-fedmdt-15(−) and sbp-1(−)
animals?We considered two possible causes: (1) decreased
UFA levels and (2) increased SFA levels. To test these
possibilities, we fed animals a glucose-rich diet with
Figure 4. RNA sequencing identifies genes
that are differentially regulated by glucose
feeding and SBP-1/MDT-15. (A,B) Heat
maps display clusters of the genes sig-
nificantly induced (A) and repressed (B) by
glucose-rich diet feeding (glc.) whose expres-
sion was reversed by sbp-1 RNAi ormdt-15
RNAi. Red boxes indicate SBP-1/MDT-15-
dependent induction (A) and repression (B)
of glucose-responsive genes.Ctrl.(RNAi) in-
dicates control RNAi-treated wild-type (N2)
worms. (C,D) Venn diagrams show that
large fractions of glucose-induced genes (C )
and glucose-repressed genes (D) are targets
of SBP-1 and MDT-15. All of the overlaps
of gene sets in C and D are significant. P <
10−50, hypergeometric probability test. (E)
Overrepresented GO terms of the 166 over-
lapping genes in C. (F ) Overrepresented
GO terms of the 248 genes in D. (∗) P <
0.05; (∗∗) P < 0.01; (∗∗∗) P < 0.001, modified
Fisher’s exact tests (Huang et al. 2009).
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either UFAs or SFAs. Treatment with the UFA mixture
(C18:1n-9, C18:1n-7, and C18:2n-6) partly restored the
short life span of glucose-fed sbp-1(RNAi) worms, al-
though the effects were variable (Fig. 7A; Supplemen-
tal Fig. S13C). Treatment with the UFA mixture or a
major MUFA (C18:1n-9) had a small or no effect on the
life span of glucose-treated mdt-15(RNAi) or mdt-15(−)
worms (Supplemental Fig. S13A–E). In contrast, an SFA
mixture (C14:0 and C16:0) or individual SFAs (C14:0 or
C16:0) dramatically decreased the life span of animals
fed a glucose-enriched diet while not reducing the life
span of animals on a control diet (Fig. 7B; Supplemental
Fig. S13F,G). Thus, accumulation of SFAs appears to be a
major cause that reduces the life span of animals on a
high glucose diet.
SFAs may be toxic and synergistically enhance the life-
shortening effects of glucose. Alternatively, the accumu-
lation of SFAs may block a metabolic flow from glucose
to SFA synthesis by inhibiting upstream enzymes and in-
creases the level of toxic intermediates (Tong and Har-
wood 2006). We sought to reduce SFAs while increasing
intermediate metabolites by genetically inhibiting key
enzymes for de novo SFA synthesis, ACC (POD-2) and
FAS (FASN-1) (Strable and Ntambi 2010). ACC(RNAi)
and FAS(RNAi) animals exhibited very short life span
phenotypes in glucose-enriched conditions (Fig. 7C–E),
Figure 5. FA desaturases are glucose-re-
sponsive targets of MDT-15 and SBP-1. (A)
A simplified schematic of the FA synthesis
pathway representing the steps that gener-
ate various SFAs, MUFAs, and PUFAs. En-
zymatic steps that were catalyzed by the
gene products of fat-5, fat-6, fat-7, and fat-
2 are indicated. (B) Knockdown of sbp-1 or
mdt-15 decreased the induction of fat-7p::
GFP on a glucose-rich diet. Bar, 200 μm.
(C ) Quantification of the data shown in
B. n≥ 27 from three independent experi-
ments. (D–G) Relative mRNA levels of fat-
2 (D), fat-5 (E), fat-6 (F ), and fat-7 (G) in
sbp-1 RNAi-treated or mdt-15 RNAi-treat-
ed wormsweremeasured by using quantita-
tive RT–PCR (qRT–PCR). sbp-1 RNAi or
mdt-15 RNAi significantly decreased the
mRNA levels of fat-2, fat-5, fat-6, and fat-7
on a glucose-rich diet. n≥ 4. (H,I ) Relative
mRNA levels of fat-5 (H) and fat-7 (I ) were
increased in sbp-1-overexpressing (sbp-1
OE) worms with or without glucose-en-
riched diet feeding. n = 4. Injection marker
(roller) transgenic worms (CL2070) were
used as a control. (J) The level of fat-7p::
GFP was increased by mdt-15(et14) gain-
of-function (gf) mutation. paqr-2(tm3410)
mutant background was used for both
control and mdt-15(gf) (Svensk et al. 2013).
Bar, 200 μm. (K,L) The sams-1(ok3033)
[sams-1(−)] mutation increased the expres-
sion of fat-5 (K ) and fat-7 (L) regardless of
glucose treatment. n≥ 5. Error bars repre-
sent SEM. (∗) P < 0.05; (∗∗) P < 0.01; (∗∗∗) P <
0.001, two-tailed Student’s t-test. (M ) An
intestinal promoter (ges-1p)-driven fat-2,
fat-5, fat-6, and fat-7 overexpression (Intes-
tinal fat-2,-5,-6,-7 OE) partly restored the
very short life span of sbp-1(RNAi) worms
upon glucose-rich diet feeding. See Sup-
plemental Fig. S10A,B and the legends for
the results regarding the effects of intesti-
nal fat-2, fat-5, fat-6, and fat-7 overexpres-
sion on mdt-15(RNAi) and Control(RNAi)
worms. We also found that genetic inhibi-
tion of multiple FA desaturases—fat-5, fat-6, and fat-7 or fat-2 and fat-5—did not have specific life span-shortening effects on a glu-
cose-rich diet (Supplemental Fig. S10C,D). This negative result can be interpreted in many different ways, including redundancy of
diverse branches in the FA synthesis pathway and of multiple FA desaturases (Fig. 5A).
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similar to mdt-15(−) or sbp-1(−) animals. In addition,
knockdown of ACC or FAS did not further decrease the
short life span of sbp-1(RNAi) or mdt-15(RNAi) worms
on a glucose-rich diet (Supplemental Fig. S14C–J). These
data suggest that ACC and FAS act in the same pathway
withMDT-15/SBP-1 and that accumulation of intermedi-
ate metabolites between glucose and FAs causes the short
life span.
To further specify the intermediate metabolites that
reduced life span, we genetically inhibited each step in
the glycolysis pathway (Fig. 7E and see also the legend
for details). Genetic inhibition of glucose-6-phosphate
isomerase (GPI) or fructose-1,6-bisphosphate aldolases
(aldolases) significantly restored life span in animals on
a glucose-rich diet (Fig. 7E–G). Thus, intermediate metab-
olites between the steps governed by aldolases and ACC
appear to shorten life span (Fig. 7E). We next treated
worms with available intermediate metabolites in glycol-
ysis, and found that dihydroxyacetonephosphate (DHAP)
significantly and consistently reduced life span (Fig. 7E,
H; Supplemental Fig. S15A–J). Together, these data sug-
gest that DHAP is the potential toxic molecule that caus-
es short life span on a glucose-rich diet.
Discussion
SREBP and MDT-15 reduce the toxic effects of dietary
glucose on life span by promoting the conversion of
glucose to UFAs
Glucose is an essential energy source, but excessive
amounts can shorten life span. In this study, we show
that SREBP and MDT-15 reduce the toxic effects of glu-
cose on life span by promoting fat conversion in C. ele-
gans. Glucose feeding up-regulates the SBP-1/MDT-15
transcription factor complex, which induces expression
of lipogenic genes, including FA desaturases. This pre-
vents further accumulation of the SFAs and intermedi-
ate metabolites, including DHAP, which reduce life span.
Thus, a normal metabolic flow from glucose to UFA syn-
thesis is required to ameliorate the life-shortening effects
of glucose. Several key data in our study support this
Figure 6. Knockdown of mdt-15 or sbp-1
increases the levels of SFAs in glucose-fed
worms. (A) Oil-Red-O staining of fixed
worms, which were previously treated with
control RNAi, mdt-15 RNAi, or sbp-1
RNAi on a control diet or a glucose-rich
diet. Bar, 100 μm. (B) Quantification of the
data shown in A. n≥ 85 from five indepen-
dent experiments. Note the variability of
the signals, particularly among the glucose-
treated mdt-15(RNAi) worms (Supplemen-
tal Fig. S11E). (C ) The total amount of FAs
in triacylglyceride (TAG) was analyzed by
using gas chromatography/mass spectrome-
try (GC/MS). n = 3. (D) Total FA profiles of
control RNAi-fed worms treated with or
without additional glucose were analyzed
by using GC/MS. n = 3. Fractions of each
FA in the sum of the total FAs (mole/mole)
were calculated. (E–G) Shown are the levels
of SFAs (E), MUFAs (F ), and PUFAs (G) in
sbp-1(RNAi) or mdt-15(RNAi) worms with
or without glucose-rich diet feeding. (H–J)
The levels of SFAs in sbp-1-overexpressing
(sbp-1 OE) (H), mdt-15(et14) gain-of-func-
tion (gf) (I ), and sams-1(ok3033) [sams-1
(−)] (J) animals. Injection marker transgenic
worms (IJ1243) were used as a control for
sbp-1-overexpressing animals, and paqr-2
(tm3410) mutant background was used for
both control and mdt-15(gf) (Svensk et al.
2013) animals. (WT) Wild type (N2). Total
SFAs are the sum of C14:0, C16:0, and
C18:0; total MUFAs are the sum of
C16:1n-9, C16:1n-7, C18:1n-9, and C18:1n-
7; total PUFAs are the sum of C18:2n-6,
C18:3n-6, C20:3n-6, C20:4n-6, C20:4n-3,
and C20:5n-3. Error bars represent SEM. (∗)
P < 0.05; (∗∗) P < 0.01; (∗∗∗) P < 0.001, two-
tailed Student’s t-test.
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model. First, both SBP-1 and MDT-15 were necessary and
sufficient for reducing the life span-shortening effect of
glucose. Second, SBP-1 andMDT-15 regulated the expres-
sion of many genes involved in fat metabolism in high
glucose feeding conditions. Third, SBP-1/MDT-15 is nec-
essary and sufficient to moderate the accumulation of
SFAs in animals on high glucose diets. Fourth, SFAs
further reduced the shortened life span of glucose-fed
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Figure 7. Accumulation of intermediate metabolites from glucose to FA synthesis causes short life span. (A) UFA mixture (600 μM
C18:1n-9, C18:1n-7, and C18:2n-6) feeding partly suppressed the short life span of the worms treated with sbp-1 RNAi on a glucose-en-
riched diet. (B) SFA mixture (600 μMC14:0 and C16:0) greatly shortened the life span of wild-type animals on a glucose-rich diet. NP-40
(0.1%) was added to all experimental conditions inA and B. (C,D) Knockdown ofACC (pod-2 RNAi) (C ) or FAS ( fasn-1 RNAi) (D) caused
very short life span upon glucose-rich diet feeding. Worms were treated with pod-2 RNAi or fasn-1 RNAi only during adulthood. (E) Sim-
plified glycolysis and FA synthesis pathways and percent changes of mean life span upon genetically inhibiting enzymes in the pathways.
See Supplemental Table S9 for the genetic inhibition used for each enzymatic step. (DHAP) Dihydroxyacetonephosphate; (G3P) glyceral-
dehyde-3-phosphate; (GPI) glucose-6-phosphate isomerase; (PFK) phosphofructokinase; (TPI) triosephosphate isomerase; (GAPDH) glyc-
eraldehyde-3-phosphate dehydrogenase; (PGK) phosphoglycerate kinase; (PGAM) phosphoglycerate mutase; (PK) pyruvate kinase; (PDH)
pyruvate dehydrogenase. Error bars represent SEM of mean life spans from two independent experiments. Colored boxes for metabolites
indicate percent changes in mean life span upon treatment with the respective metabolites. (N.D.) Not determined. See Supplemental
Figure S15 and its legend for details. (F ) Knockdown ofGPI (gpi-1 RNAi) partly suppressed the short life span of glucose-treated animals.
Note that previous reports showed that gpi-1 RNAi increased life span under normal feeding conditions (Hansen et al. 2005; Schulz et al.
2007), but it did not do so in our experimental conditions.We speculate that different experimental conditions (e.g., FUdR treatment) may
have caused these different results. (G) Aldolases(−) [aldo-1(tm5782)mutation with aldo-2 RNAi treatment] largely suppressed the glu-
cose toxicity on life span. Life span curves in C, D, F, and G are representative data of those shown in E. (H) DHAP treatment greatly
reduced life span. See Supplemental Table S9 for additional repeats and statistical analysis for life span data shown in this figure.
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animals. Fifth, genetic inhibition of de novo FA synthesis
enhanced the life span-shortening effect of glucose. These
results indicate that an SBP-1/MDT-15-dependent meta-
bolic flow from glucose via SFAs to UFAs moderates the
life-shortening effect of glucose.
What toxic, life-shortening molecules could a glucose-
rich diet produce? Excessive glucose directs a metabolic
flow that favors FA synthesis. Increased levels of SFAs
inhibit enzymes, such as ACC, by feedback regulation,
which inhibits de novo fat synthesis (Tong and Harwood
2006). This may promote the accumulation of toxic in-
termediate metabolites in the glycolysis and FA synthesis
pathways. Consistent with this model, we found that SFA
feeding or inhibition of de novo FA synthesis enhanced
the toxic effect of glucose on life span. Our data also indi-
cate that intermediate metabolites, such as DHAP, have a
life-shortening effect on a glucose-rich diet. Interestingly,
DHAP is known to glycate proteins to generate advanced
glycation end products (AGEs) (Hipkiss 2011). Consistent-
ly, a glucose-rich diet increases the levels of AGEs in
C. elegans (Schlotterer et al. 2009). Thus, DHAP is likely
to be accumulated in mdt-15(−) and sbp-1(−) animals in
response to glucose feeding, which leads to a very short
life span.
One of the limitations of our study results from the fact
that full inactivation of the key lipogenic genes such as
sbp-1, mdt-15, pod-2, or fasn-1 appears to cause lethality
or growth defects. Because of this, we tested the phys-
iological roles of these genes by using hypomorphicmuta-
tions, whole-life RNAi, or adult-only RNAi, which results
in partial inhibition of the genes. Although these par-
tial inhibition methods elicited glucose-specific life span
phenotypes, our data regarding the effects of SBP-1 and
MDT-15 inhibition on the expression of glucose-respon-
sive genes or in overall fat synthesis were partial and
should be interpreted with caution. It will be important
to completely inhibit SBP-1 and MDT-15 in adulthood
by exploiting new genetic tools, such as inducible knock-
out systems, in future studies.
Glucose-responsive lipid metabolism
by SREBP and FOXO
The regulation of glucose-responsive lipid metabolism by
SREBPs appears to be conserved from nematodes to mam-
mals. Consistent with our data, glucose treatment up-
regulates SREBPs in mammals and induces key lipogenic
genes, such as ACC, FAS, and SCDs (Horton et al. 1998;
Hasty et al. 2000). Glucose treatment increases ER
stress, which activates SREBPs that are localized at the
ER membrane (Wang et al. 2005). In addition, the nuclear
liver X receptor (LXR) up-regulates SREBP-1 in response
to glucose or insulin (Chen et al. 2004; Mitro et al.
2007). Glucose feeding decreases the activity of 5′-adeno-
sine monophosphate-activated protein kinase (AMPK)
in C. elegans (Schulz et al. 2007). Mammalian AMPK
directly phosphorylates and inhibits SREBPs (Li et al.
2011). Thus, glucose treatment may decrease the activity
of AMPK, relieving the inhibition of SBP-1 to promote
lipogenesis.
Our previous study showed that glucose-rich diets
shorten C. elegans life span by down-regulating the
DAF-16/FOXO transcription factor and a glycerol channel
(Lee et al. 2009). Interestingly, DAF-16/FOXO and glycer-
ol channels are tightly associated with fat metabolism.
Activation of DAF-16/FOXO increases fat levels and regu-
lates the expression of key fat metabolism-related genes
(Kimura et al. 1997; Murphy et al. 2003). Moreover, mu-
tant mice lacking glycerol channel AQP7 have metabolic
defects such as obesity or diabetes (Hibuse et al. 2005).
This may be caused by defective glycerol usage, which
can disturb proper fat metabolism, as glycerol is a crucial
building block for triglyceride synthesis. Therefore, it will
be interesting to determine whether DAF-16/AQP-1 and
SBP-1/MDT-15 pathways interact with each other to reg-
ulate life span and fat metabolism on a glucose-rich diet.
Association of fat and glucose metabolism by SREBPs
in pathology and aging models
Glucolipotoxicity underlies the deleterious effects of
chronically high levels of glucose and FAs in pancreatic
β cells (Poitout et al. 2010). Excessive amounts of glucose
and FAs cause a functional decline and apoptosis of β cells,
leading to metabolic disorders such as diabetes (Poitout
et al. 2010). Our data are related to the glucolipotoxicity
model at the organismal level because SFAs cause rapid
death in animals fed a high glucose diet. In addition, our
data regarding the beneficial effects of FA desaturase over-
expression are consistent with the protective roles of
mammalian SCD1 in SFA-induced pancreatic β-cell death
(Busch et al. 2005). In contrast, mammalian SREBPs in-
crease fat levels by promoting fat synthesis, which leads
to glucolipotoxicity (Wang et al. 2003). This seems differ-
ent from our current finding that SBP-1 moderated the
toxic effects of glucose on C. elegans life span. Mammali-
an SREBPs regulate the expression of genes such as ACC
and FAS, which are crucial for de novo FA synthesis (Hor-
ton et al. 1998; Hasty et al. 2000). Therefore, up-regulation
of SREBPs increases the overall levels of FAs, including
SFAs, which may enhance glucolipotoxicity. Our data in-
dicate that C. elegans SBP-1 is crucial for the conversion
of SFAs to UFAs (which reduces the life-decreasing effects
of dietary glucose) as well as de novo fat synthesis. Thus, it
will be crucial to determine detailed mechanistic roles of
mammalian SREBPs in fat metabolic processes under glu-
cose-rich conditions.
Activation of SREBPs is also linked to obesity, fatty liv-
er diseases, and cardiovascular diseases (Walker and Näär
2012). Excessive SREBP activity can increase circulat-
ing cholesterol and lipids, which causes an accumula-
tion of lipids in the liver and adipose tissues (Walker and
Näär 2012). An adipose tissue-specific overexpression of
SREBP-1c causes severe insulin resistance and high blood
glucose (Shimomura et al. 1998). In contrast, SREBP-in-
duced hepatic lipogenesis can reduce glucose toxicity by
lowering blood glucose levels in mouse models (Becard
et al. 2001; Takahashi et al. 2005). The C. elegans intes-
tine is a major tissue for metabolism, similar to the mam-
malian liver (McGhee 2007). Thus, our data showing the
SREBP/MDT-15 prevents glucose-induced short life
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beneficial effects of intestinal SBP-1 on glucose toxicity
and life span are functionally relevant to data obtained
in mouse models. It will be interesting to test the role of
hepatic SREBPs in aging upon exposure to a high carbohy-
drate diet or in a diabetic model.
Materials and methods
Strains
All strains used in this study are described in the Supplemental
Material.
Fluorescence imaging
Fluorescence imaging was performed as described previously
withmodifications (Gaglia et al. 2012). For glucose-rich diet feed-
ing experiments, transgenic worms were fed with specific RNAi
bacteria with or without 2% glucose from eggs to day 1 adults un-
less otherwise mentioned. sbp-1p::GFP::sbp-1 transgenic worms
were treated with glucose from eggs to L4 larval stage. L4 larvae
were chosen for sbp-1p::GFP::sbp-1 worm imaging because eggs
in adult worms interfered with fluorescence signals from intesti-
nal cells. mdt-15p::mdt-15::GFP worms were treated with glu-
cose from eggs to L2 larval stage. Signals of the GFP-fused
MDT-15were strong at L2 stage but decreased during subsequent
development. The transgenic worms were mounted on a 2% aga-
rose pad and anesthetized by using 100 mM sodium azide (Dae-
jung). Images of the worms were captured by using an AxioCam
HRc (Zeiss Corporation) camera attached to a Zeiss Axioscope
A.1 microscope (Zeiss Corporation). ImageJ (Schneider et al.
2012) was used to quantify the fluorescence intensity of whole
body, and the background signals were subtracted. Formeasuring
the intestinal expression of fat-6p::fat-6::GFP or fat-7p::GFP, the
first anterior intestinal cells were quantified as described previ-
ously (Lemieux et al. 2011).
Genome-wide RNAi screen
The genome-wideRNAi screenwas performed as described previ-
ously with modifications (Lamitina et al. 2006). See the Supple-
mental Material for details.
Life span assays
Life span assays were performed as described previously with
some modifications (Lee et al. 2010). Statistical analysis of life
span results was performed by using OASIS (Online Application
of Survival Analysis, http://sbi.postech.ac.kr/oasis), and P-values
were calculated by using a log rank (Mantel-Cox method) test
(Yang et al. 2011). See the Supplemental Material for details.
Oil-Red-O staining
Oil-Red-O staining was performed as described previously with
some modifications (O’Rourke et al. 2009). Worms were treated
with specific RNAi with or without additional 2% glucose feed-
ing from eggs to adulthood. Approximately 300 young adult (day
1) worms were then harvested with M9 buffer by washing three
times and fixed with 50% isopropanol for 15 min. Oil-Red-O sol-
ution (0.5 g/100 mL in isopropanol; Sigma) was diluted in double
distilledwater (ddH2O) to 60%working solution, and precipitates
were eliminated by filtering. Fixed worms were incubated in the
working solution overnight at room temperature. Stained worms
were washed with PBS (137 mMNaCl, 2.7 mMKCl, 10 mMNa2-
HPO4, 2 mM KH2PO4), and PBST (PBS with 0.01% Triton X-100
[Daejung]) was used for placing the worms on a 2% agarose pad
with micropipettes. DIC images were captured using an Axio-
Cam HRc (Zeiss Corporation) camera attached to a Zeiss Axio-
scope A.1 microscope (Zeiss Corporation). ImageJ was used for
the quantification of Oil-Red-O intensity (Schneider et al. 2012;
Mehlem et al. 2013). Images were inverted, and thresholds were
set as 90 for Oil-Red-O signals. Areas that had higher intensities
than the threshold in anterior intestinal cells were quantified.
Locomotion assays
Locomotion was measured as described previously with modifi-
cations (Bansal et al. 2015). See the Supplemental Material for
details.
mRNA sequencing and data analysis
Total RNA was isolated as described previously with modifica-
tions (Seo et al. 2015). Synchronized wild-type worms were treat-
ed with control RNAi (L4440), sbp-1 RNAi, or mdt-15 RNAi
during development with or without additional 2% glucose treat-
ment and harvested at day 1 adult stage. Total RNA of theworms
was extracted by using RNAiso plus (Takara) and purified by us-
ing ethanol precipitation. Three independent biological repeats
were used. The cDNA library was prepared by ChunLab (Chun-
Lab, Inc.), and cDNA sequencingwas performed by using a HiSeq
2500 platform. Quality-filtered reads were aligned to the refer-
ence genome sequence (Caenorhabditis elegans Bristol N2 [ac-
cession no. GCF_000002985.6]) by Bowtie2 (Langmead and
Salzberg 2012), and differentially expressed genes were analyzed
using the edgeRmethod (Robinson et al. 2010) by the CLRNASeq
program (ChunLab, Inc.). Genes with significant changes in ex-
pression (P < 0.05, fold change >1.2) (Yao et al. 2015) were further
analyzed, and genes whose FPKM (fragments per kilobase of tran-
script per million fragments) was zero were excluded. Scatter plot
(Riedel et al. 2013) and heat map analyses (Ewald et al. 2015)
were performed as previously described. Heat maps were generat-
ed by using Cluster 3.0 (Eisen et al. 1998) and Java Treeview (Sal-
danha 2004). Venn diagrams were generated by using Venn
Diagram Plotter (http://omics.pnl.gov/software/venn-diagram-
plotter). The significance of the overlaps among gene sets was
calculated by using the hypergeometric probability test (https://
www.geneprof.org/GeneProf/tools/hypergeometric.jsp) (Halbrit-
ter et al. 2012).
Quantitative RT–PCR (qRT–PCR)
qRT–PCR was performed as described previously (Seo et al.
2013). Synchronized worms treated with sbp-1 RNAi or mdt-15
RNAi from eggs with or without 2% glucose treatment were
harvested at young adult stage (day 1) with M9 buffer by wash-
ing three times. Synchronized worms were cultured on control
RNAi with or without 2% glucose until L4 stage and then trans-
ferred onto pod-2 RNAi or fasn-1 RNAi plates. The pod-2
RNAi-treated or fasn-1RNAi-treatedwormswere harvested after
24 h with M9 buffer by washing three times. RNA was isolated
using RNAiso plus (Takara) and reverse-transcribed to cDNA
using ImProm-II reverse transcriptase kit (Promega). Random
primers (9-mers; Cosmogenetech) were used for reverse tran-
scription except for the measurement of sbp-1 mRNA (Supple-
mental Fig. S6C), which was reverse-transcribed with oligo(dT)
15 primer (Promega). Quantitative real-time PCR was performed
by using the StepOne real-time PCR system (Applied Biosys-
tems), and relative quantity was analyzed by using comparative
Ctmethods described in themanufacturer’smanual. The average
Lee et al.
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of two technical repeats was used for each biological data set.
mRNA levels of ama-1, which encodes an RNA polymerase
II large subunit, were used for normalization. See the Supplemen-
tal Material for the sequence information of the primers used for
the assays.
Lipid extraction and GC/MS assays
Lipid extraction was performed as described previously with
somemodifications (Yang et al. 2006). Day 1 adult worms treated
with sbp-1 RNAi or mdt-15 RNAi from eggs with or without
2% glucose feeding were harvested and washed three times
with ddH2O. Synchronized GFP::sbp-1-overexpressing animals
and sams-1 mutants were cultured on OP50-seeded plates with
or without 2% glucose treatment. paqr-2(tm3410) and mdt-15
(et14) paqr-2(tm3410) worms were cultured on OP50-seeded
plates without glucose addition until L4 stage and then trans-
ferred onto newOP50-seeded plates with or without 2% glucose.
The worms were harvested after 24 h and washed three times
with ddH2O. Approximately 400 μL of worm pellets was frozen
in liquid nitrogen and stored at −80°C until use. The worm sam-
ples were homogenized by sonication on ice, and 10 μL of the
worm lysates was used for quantifying total protein amount by
using the BCA protein assay kit (Thermo). For each condition,
300 μL of worm lysate samples was used for the assay. Five milli-
liters of ice-cold chloroform/methanol (1:1) was added to each
sample in a glass tube, followed by vortexing and incubation over-
night at 4°C. After the incubation, 2mL of Hajra’s solution (0.2M
H3PO4, 1MKCl) was added to the samples andmixedwell. Chlo-
roform layer and aqueous phase were separated by centrifugation
(2000 rpm for 10 min), and the chloroform layer-containing lipid
was extracted. Aqueous phase was re-extracted by the addition of
3 mL of chloroform followed by centrifugation. The combined
chloroform layers were evaporated to 120 μL. Twenty microliters
of the lipid extract was used for analyzing total lipid extract, and
the remaining sample was separated by using thin-layer chroma-
tography (TLC) to analyze TAG. To visualize lipids, 0.01% puri-
murin/80% acetone solution was used, and the lipid spots
corresponding to TAG were scraped off. FA methyl esters were
prepared by using sulfuric acid (2.5%)/methanol solution and
analyzed by GC/MS (GCMS-QP2010, Shimadzu; HP-INOWAX
capillary column, 30 m, 0.25 mm; Agilent).
Preparation of plates for FA feeding assays
FA feeding assays were performed as described previously with
modifications (Yang et al. 2006). See the Supplemental Material
for details.
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